Nanoparticle vaccine for COVID-19 spurs robust immune response in preclinical tests The novel vaccine technology, developed at Scripps Research, uses virus-like protein nanoparticles to elicit high levels of protective antibodies.
September 21, 2020
LA JOLLA, CA In a new study that demonstrates the promise of a novel vaccine approach for COVID-19, Scripps Research scientist Jiang Zhu, PhD, showed that his protein nanoparticle technology successfully triggered a strong immune response in mice. Zhu, who co-founded the spinoff company Ufovax to commercialize the technology and manufacturing platform, says he hopes to advance the vaccine into clinical trials early next year.
The nanoparticle vaccine technology leverages a unique design that's unlike the majority of other COVID-19 vaccine candidates now in clinical testing. Each nanoparticle in the vaccine mimics the natural ball-like shape of a virus, which the immune system is trained to immediately recognize, explains Zhu, associate professor in the Department of Integrative Structural and Computational Biology.
These microscopic spheres are then studded with spike proteins resembling those of the SARS-CoV-2 virus.
Spike proteins are the tools this virus uses to efficiently attach to and infect healthy cells, so we need the immune system to recognize them as the enemy, Zhu says. Our vaccine design enables immune cells to encounter these proteins in a more natural conformation embedded on a spherical particle so they'll know what to do when they face the virus in real life.
By contrast, most experimental COVID-19 vaccines rely on full-length spike proteins that have been modified to remain stable in the body as they interact with the immune system; they are not connected to a virus-like particle. Thus, they may not generate strong enough of an antibody response to prevent COVID-19, Zhu says.
In his pursuit of a safer and more effective path to COVID-19 immunity, Zhu designed spike proteins and attached them to the spherical protein nanoparticles through an elegant self-assembly process he says will ensure the forming a ball-shape particle of a fixed size and enable efficient vaccine production on an industrial scale.
Notably, as part of their work to optimize the spike protein, he and his team identified a problematic element of the spike called the HR2 stalk, which is a flexible hinge connecting the spike to the virus surface, and decided to delete that segment from spike proteins used in the vaccine.
The scientists then tested the nanoparticle vaccine against the altered spike protein known as S2P that's used in most other vaccines, as well as against their own engineered spike protein. To determine efficacy of each approach, they measured antibody responses in mice.
Zhu's nanoparticle vaccine elicited neutralizing antibodies at levels of up to ten times greater than the S2P spike proteins alone and induced critically needed T-cell immunity. The research appears in bioRxiv, an open-access repository of studies not yet published in a peer-reviewed scientific journal.
Our study provides a promising next-generation COVID-19 vaccine candidate that is ready for evaluation in human trials, Zhu says.
Zhu has previously used his nanoparticle technology to develop investigational vaccines for other infectious diseases including SARS, MERS, HIV, RSV, Ebola, malaria and tuberculosis.
The study, Self-assembling nanoparticles presenting receptor binding domain and stabilized spike as next-generation COVID-19 vaccines, was authored by Linling He, Xiaohe Lin, Ying Wang, Ciril Abraham, Cindy Sou, Timothy Ngo, Yi Zhang, Ian Wilson and Jiang Zhu.
The work was funded by the National Institutes of Health [AI129698 and AI140844] and Ufovax. Ufovax holds exclusive intellectual property rights to the technology and several vaccine products, including for COVID-19.
COVID-19 Zhu, Jiang
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
01/06/2026
January 6 2026, 05:30 (PST) Dolby Sets the New Standard for Premium Entertainment at CES 2026
Throughout the week, Dolby brings to life the latest innovatio...
01/05/2026
January 5 2026, 18:30 (PST) NBCUniversal's Peacock to Be First Streamer to ...
01/04/2026
January 4 2026, 18:00 (PST) DOLBY AND DOUYIN EMPOWER THE NEXT GENERATON OF CREATORS WITH DOLBY VISION
Douyin Users Can Now Create And Share Videos With Stun...
28/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Bluesky
Email...
28/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Bluesky
Email...
28/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Bluesky
Email...
28/01/2026
28 01 2026 - Media release Screen Australia refreshes Market & Audience approach...
28/01/2026
Boston Conservatory Orchestra Premieres a New Piano Concerto by Peter and Leonar...
27/01/2026
Click for Japanese version
Tokyo, Japan - January 27, 2026 - Akamai Technolo...
27/01/2026
L-R: Jonathan Cuchacovich, Sonia Kennebeck, Alan Fischer, Daeil Kim, Andrew Sta...
27/01/2026
Today, Spotify is proud to support our partner Backline, an industry-leading men...
27/01/2026
With nearly 29 million monthly listeners and clear momentum on Spotify, Net n Ve...
27/01/2026
January 14, 2026
We are proud to share that 25 Ontario, First Gulf's commercial project located just two minutes from our head office, has been recognized ...
27/01/2026
January 22, 2026
First Gulf is excited to share that a full-building lease has been secured at 625 Bronte Rd in Oakville, part of Bronte Station Business Park,...
27/01/2026
January 23, 2026
First Gulf continues to demonstrate its commitment to high-performance, sustainable real estate with 351 King Street East achieving BOMA BEST ...
27/01/2026
eds3_5_jq(document).ready(function($) { $(#eds_sliderM519).chameleonSlider_2_1({ content_source:......
27/01/2026
Nielsen will continue to drive growth and provide local audience measurement
in...
27/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Pinterest
Bluesky
Email...
27/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Pinterest
Bluesky
Email...
27/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Pinterest
Bluesky
Email...
27/01/2026
Amagi Media Labs Limited, the only cloud-native SaaS provider offering end-to-end solutions across live production, content preparation, distribution, and monet...
27/01/2026
Miri Technologies Inc. today unveiled its V410 live 4K video encoder/decoder for streaming, IP-based production workflows and AV-over-IP distribution. Designed ...
27/01/2026
The Paul E. Tsongas Center at UMass Lowell in Massachusetts has chosen Ikegami cameras for incorporation into its broadcast-quality television production facili...
27/01/2026
SipRadius, specialists in secure, low latency media transport, will show the pro AV community its end-to-end solution for high quality content distribution and ...
27/01/2026
Hiltron will highlight the fruits of its 45-plus years of experience in satellite communications system integration and product development at the annual GovSat...
27/01/2026
Klvr will demonstrate how its Charger Pro solution is delivering cost reduction and performance benefits for live entertainment and pro AV markets at ISE 2026 (...
27/01/2026
Amino, a global media technology leader in enterprise video and digital signage, today announced that its Integrated Systems Europe (ISE) 2026 booth (4N700) wil...
27/01/2026
ANI, India's leading news agency and a major content provider across the Asia Pacific region, today announced a significant expansion of its long standing p...
27/01/2026
Independent analysis confirms faster encoding, lower CPU usage, and improved perceptual quality compared to CBR and CRF
VisualOn, a leader in multimedia playba...
27/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Pinterest
Bluesky
Email...
27/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Pinterest
Bluesky
Email...
27/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Pinterest
Bluesky
Email...
27/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Pinterest
Bluesky
Email...
27/01/2026
New agreement for uninterrupted UHF connectivity for Australian Defence Force through 2033, With Options Extending to 2041
Luxembourg, January 13, 2026 - Satel...
27/01/2026
Tuesday 27 January 2026
SNL UK creative team expands as Pauli Lovejoy, Annie Ha...
27/01/2026
Back to All News
When It Feels Real, Is It Still a Lie? The Art of Sarah' ...
27/01/2026
Back to All News
That Night premiering on Netflix March 13
Entertainment
27 January 2026
GlobalSpain
Link copied to clipboard
DOWNLOAD THE KEY ART
DOWNLO...
27/01/2026
Back to All News
Netflix Revealed the Future of Mexican Stories Coming in 2026
Entertainment
27 January 2026
GlobalMexico
Link copied to clipboard
Among t...
27/01/2026
Back to All News
Four New Japan Titles Announced for 2026: Viral Hit', On...
27/01/2026
Back to All News
What's Next on Netflix from Japan: Expanding the Possibili...
27/01/2026
AI, graphics and virtual software power new production capabilities...
27/01/2026
RT Supporting the Arts is delighted to support a dynamic programme of cultural events taking place across Ireland this February. From visual art, film, music, ...
26/01/2026
Music videos play a huge part in how fans connect with their favorite songs, but...
26/01/2026
NAIDOC launches 2026 theme 50 Years of Deadly , marks major milestone
25 January, 2026
Media releases
The National NAIDOC Committee has today unveiled its...
26/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Pinterest
Bluesky
Email...
26/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Pinterest
Bluesky
Email...
26/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Pinterest
Bluesky
Email...
26/01/2026
Share Share by:
Copy link
Facebook
X
Linkedin
Pinterest
Bluesky
Email...
Nanoparticle vaccine for COVID-19 spurs robust immune response in preclinical tests The novel vaccine technology, developed at Scripps Research, uses virus-like protein nanoparticles to elicit high levels of protective antibodies.
